EU pharma body welcomes president-elect’s mission letter

European Federation of Pharmaceutical Industries and Associations ( EFPIA) has welcomed a mission letter from the EU president-elect, which promises to invest in new health sector technologies, promote healthy lifestyles and forge better cooperation within the EU.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

HeartFlow targets AI cardiac imaging rival over patents and trade secrets

27 October 2026 The 179-page lawsuit alleges that a Boston-based company used patented technology and confidential information from former employees to develop a competing cardiac imaging product.

Careers

Womble Bond Dickinson loses trio of partners to US rival

27 October 2026 The departing partners bring expertise across molecular biology, biochemistry, small molecule and peptide drugs, including blockbuster therapies, as well as chemical and mechanical technologies.

In-house counsel

‘Companies that don’t leverage AI will struggle to keep up’: Umicore IP chief

26 October 2026 Umicore’s Sean Alexander has seen the profession change considerably over three decades, but some of its biggest changes may still lie ahead. He tells LSIPR why AI is prompting difficult decisions, what he is no longer willing to pay external counsel for and why Europe is the place to watch.